TAMPA, Fla., Sept. 26, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a leading source of low-cost prescription medications for millions of Americans who have no prescription insurance coverage, announces a new corporate management team of veterans of the prescription drug and laboratory testing industries.
Rx Processing Corporation, as a public company operating in the trillion dollar pharmaceutical and laboratory industries, recognized at inception the markets of sourcing prescription drugs domestically and internationally needed a management team focused on assurances, compliance, efficacy and safety.
Initially, as the stable market for sourcing prescription drugs developed, there were political questions of product safety and management assurances that U.S. consumers would not be harmed when ordering their prescription drugs. The focus of Rx Processing Corp was to acquire the primary entities engaged in the industry and develop standards to self-govern the industry. Peter Fiorillo recognized unwavering resolve was needed to accomplish this necessary task.
The resolves of Peter Fiorillo and Rx Processing Corp have led to the implementation of the necessary market controls and policies for self governance. Many critics do not understand what the entire scope of the business is or why the necessary actions of Rx Processing Corp have been taken in the past.
Our critics can now rest assured that Rx Processing Corp has surrounded itself with conservative individuals who have put their reputations on the line, because Rx Processing Corp is truly resource conservative, politically correct and focused on making health care more affordable.
Today, it is with great pleasure we announce the Directors and Corporate officers that have taken the helm of Rx Processing Corp.
Peter Fiorillo: Chairman of the Board/Chief Executive Officer Tim Murphy: Chief Financial Officer/Chief Operations Officer Tim Gillesse: Chief Technology Officer Tim Hayes: Director of Pharmacy Services John Bell: Director of Laboratory Services Jacqueline Amadio: Director of Human Resources
Officers Statement, "As your new corporate officers and directors we are committed to conservatively operating Rx Processing Corp. In the future you can expect deliberate actions to increase product distribution, control corporate assets and protect shareholder value. As a team we are contributing resources and time, and have placed our reputations with Rx Processing Corp to build the future of the right and just mission to achieve 'Affordable health care for all mankind, without prejudice.'"
Peter Fiorillo, CEO of Rx Processing, commented, "Our management is prepared for the impending conflicts that will surround making healthcare more affordable for U.S. Citizens. We are up for the challenge and have been positioned to enable our clients to take back personal control of their health care needs that were lost to government and Industry."
Corporate officers and directors resumes are located on www.rxprocessingcorp.com
About Rx Processing
Rx Processing is positioned to become a market leader in providing prescription drugs, lab tests and drug tests to U.S. citizens, corporations, unions, and members through FDA-approved patient service centers for their lab testing and licensed pharmacies in the United States and Canada. The Company provides access to approved brand name and generic medications as well as over 1,000 lab tests through storefront locations with access to 4,000 FDA-approved patient service centers for their lab testing. Rx Processing estimates that more than 40 million Americans could benefit from the company's low-cost prescription drugs, lab testing and drug screening
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.